- About Us
- Services & Solutions
- Technologies
- Discovery
- Reagent Materials Generation
- Monoclonal Antibody Discovery
- Bispecific & Multispecific Antibody Generation
- Lead Optimization
- In Vitro Lead Characterization
- In Vivo Lead Characterization
- Other Molecular Modalities
- IND Filing Support
- Protein Sciences
- Antibody Production
- Protein Production
- Protein Characterization
- Protein Sciences
- Mammalian
- Microbial
- mRNA
- Viral Vaccines
- WuXi XDC – Bioconjugation
- Testing
- Sustainability
- Careers
- Investors
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- SustainabilityAbout Us
- CareersAbout Us
- InvestorsAbout Us
- News & ResourcesAbout Us
Services & Solutions
Information Downloads
Microbial-based Production
Integrated service offerings from comprehensive strain development to drug product manufacturing
|
WuXi Biologics provides comprehensive CMC development and GMP manufacturing services for a wide range of biologics and vaccines produced from microbial-based production systems as well as critical raw materials (e.g., enzymes, protein reagents) that are used in various applications. With world-class facilities and highly efficient project management systems, we provide end-to-end services from strain development to regulatory filing and beyond. |
Discuss This Service Overview
To discuss the information in this service overview, please complete the form on the following page to connect with our experts.